Difference between revisions of "I-123 Biomarker Committee"

Revision as of 20:49, 16 November 2018

Co-chairs: John Dickson, PhD; John Seibyl, MD

Secretary: Julie Lisiecki

Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases

Revision as of 20:49, 16 November 2018 (view source) Jlisiecki (talk \| contribs) m (→‎Reference Materials) ← Older edit		Revision as of 20:49, 16 November 2018 (view source) Jlisiecki (talk \| contribs) m (→‎Reference Materials) Newer edit →
Line 16:		Line 16:
	==Reference Materials==		==Reference Materials==

−	*[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf \| QIBA SPECT I-123 Biomarker Committee Presentation]] ''John Seibyl, MD''	+	*[[Media:QIBA SPECT I-123 BC (11.16.2018).pdf \| QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018)]] ''John Seibyl, MD''